Wire · opportunities
twiist™ Automated Insulin Delivery System is Now Cleared for Adults with Type 2 Diabetes
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 16 October 2026 · Fusion42 review
The twiist Automated Insulin Delivery System has received FDA clearance for adults with insulin-treated type 2 diabetes, expanding its use beyond type 1 diabetes and enabling immediate prescribing in the U.S. The system improves glycemic control, increases time in target glucose range, and simplifies insulin management for users without prior pump or carb-counting experience.
This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it.
◆ ◆ The Wire takeaway
Medtech founders in diabetes management need to act fast as automated insulin delivery shifts from type 1 to type 2 diabetes, unlocking a much larger market with simpler user requirements and no prior pump experience needed. This clearance opens a door to compete in a space where easier adoption and improved patient outcomes create fresh opportunities.
◆ Coverage
2 sources · 16 Oct 2026
◆ Related on Wire
◆ Topics